Skip to content
healthcare.dev

Hydralazine Hydrochloride

NDC 70518-4064, Hydralazine Hydrochloride, tablet, from REMEDYREPACK INC..

Product NDC
70518-4064
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA040858
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4064 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HYDRALAZINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Arteriolar Vasodilation [PE]; Arteriolar Vasodilator [EPC]

Package NDCNDC-11Package
70518-4064-270518406402180 TABLET in 1 BOTTLE, PLASTIC (70518-4064-2)
70518-4064-37051840640390 TABLET in 1 BOTTLE, PLASTIC (70518-4064-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6c40d818-77a9-492c-b9b6-d8a0fe8d6736

Use it

Look up 70518-4064 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4064 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-4064. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.